Addressing antibiotic abuse in China: An experimental audit study

Journal of Development Economics

Volumn 110, Issue , 2014, Pages 39-51

  Currie, Janet ^a   Lin, Wanchuan ^b   Meng, Juanjuan ^b  

^a PRINCETON UNIVERSITY   (United States)

^b Peking University   (China)

Author keywords

Antibiotic abuse; Audit study; China

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; EXPERIMENTAL STUDY; INCENTIVE; PUBLIC HEALTH;

CHINA;

EID: 84903477189     PISSN: 03043878     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdeveco.2014.05.006     Document Type: Article

References (62)

1. Bennett Daniel, Hung Che-Lun, Lauderdale Tsai-Ling Health care competition and antibiotic use in Taiwan. J. Ind. Econ. 2014, (forthcoming).
2. Brennan Troyen A., Rothman David J., Blank Linda, Blumenthal David, Chimonas Susan C., Cohen Jordan J., Goldman Janlori, Kassirer Jerome P., Kimball Harry, Naughton James, Smelser Neil Health industry practices that create conflicts of interest. JAMA 2006, 295:429-433.
3. Camerer Colin Gifts as economic signals and social symbols. Am. Sociol. Rev. 1988, 94:180-214.
4. Carmichael H.Lorne, MacLeod W.Bentley Gift giving and the evolution of cooperation. Int. Econ. Rev. 1997, 38:485-509.
5. Cars Håkan, Håkansson Anders To prescribe-or not to prescribe-antibiotics: district physicians' habits vary greatly, and are difficult to change. Scand. J. Prim. Health Care 1995, 13:3-7.
6. Chen Wang, Tang Shenglan, Sun Jing, Ross-Degnan Dennis, Wagner Anita K. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Serv. Res. 2010, 10(1):211-218.
7. Cheng Wei, Fang Yunyun, Fan Dehui, Sun Jing, Shi Xuefeng, Li Jiao The effect of implementing "medicines zero mark-up policy". Southern Med Review 2012, 5(1):53-56.
8. Currie Janet, Lin Wanchuan, Zhang Wei Patient knowledge and antibiotic abuse: evidence from an audit study in China. J. Health Econ. 2011, 30:933-949.
9. Currie Janet, Lin Wanchuan, Meng Juanjuan Social networks and externalities from gift exchange: evidence from a field experiment. J. Public Econ. 2013, 107:19-30.
10. Dai Honglei, Fang Lizheng, Malouin Rebecca A., Huang Lijuan, Yokosawa Kenneth E., Liu Guozhen Family medicine training in China. Fam. Med. 2013, 45(5):341-344.
11. Dana Jason, Loewenstein George A social science perspective on gifts to physicians from industry. JAMA 2003, 290:252-255.
12. Dar-Odeh Najla Saeed, Abdalla Abu-Hammad Osama, Al-Omiri Mahmoud Khaled, Khraisat Ameen Sameh, Shehabi Asem Ata Antibiotic prescribing practices by dentists: a review. Ther. Clin. Risk Manag. 2010, 6:301-306.
13. Das Jishnu, Holla Alaka, Das Veena, Mohanan Manoj, Tabak Diana, Chan Brian In urban and rural India, a standardized patient study showed low levels of provider training and huge quality gaps. Health Aff. 2012, 31(12):2774-2784.
14. Dieperink Michael E., Drogemuller Lisa Drogemuller Industry-sponsored grand rounds and prescribing behavior. JAMA 2001, 285:1443-1444.
15. Eggleston Karen, Yip Winnie Hospital competition under regulated prices: application to urban health sector reforms in China. Int. J. Healthc. Financ. Econ. 2004, 4(4):343-368.
16. Eggleston Karen, Li Ling, Meng Qingyue, Magnus Lindelow, Adam Wagstaff Health service delivery in China: a literature review. Health Econ. 2008, 17(2):149-165.
17. Fang Yu., Yang Shimin, Zhou Siting, Jiang Minghuan, Liu Jun Community pharmacy practice in China: past, present and future. Int. J. Clin. Pharm. 2013, 35(4):520-528.
18. Feng Minghai, Chu Wengong, Wang Dashui Analysis on the advantages and disadvantages of the hospital pharmacy trusteeship. J. Pharm. Pract. 2012, 30(01):67-77. (in Chinese).
19. Halperin Edward C., Hutchison Paul, Barrier Robert C. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. J. Radiat. Oncol. 2004, 59:1477-1483.
20. Heckman James, Siegelman Peter The urban institute audit studies: their methods and findings. Clear and Convincing Evidence: Measurement of Discrimination in America 1993, Urban Institute Press, Lanham, MD. M. Fix, R. Struyk (Eds.).
21. Hollon M.F., Larson E.B., Koepsell T.D., Downer A.E. Direct-to-consumer marketing of osteoporosis drugs and bone densitometry. Ann. Pharmacother. 2003, 37(7):976-981.
22. Hsiao William C. Containing Health Care Costs in Japan 1996, University of Michigan Press, Michigan. N. Ikegami, J. Campbell (Eds.).
23. Hsiao William C., Liu Yuanli Economic reform and health-lessons from China. N. Engl. J. Med. 1996, 335:430-432.
24. Huang Ying, Jiarui Gu., Zhang Mingyu, Ren Zheng, Yang Weidong, Chen Yang, Yingmei Fu., Chen Xiaobei, Cals Jochen W.L., Zhang Fengmin Knowledge, attitude and practice of antibiotics: a questionnaire study among 2500 Chinese students. BMC Med. Educ. 2013, 13:163.
25. Iizuka Toshiaki Experts' agency problems: evidence from the prescription drug market in Japan. RAND J. Econ. 2007, 38:844-862.
26. Iizuka Toshiaki Physician agency and adoption of generic pharmaceuticals. Am. Econ. Rev. 2012, 102(6):2826-2858.
27. Jagsi Reshma Conflicts of interest and the physician-patient relationship in the era of direct-to-patient advertising. J. Clin. Oncol. 2007, 25(7):902-905.
28. Kravitz Richard L. Direct-to-consumer advertising of prescription drugs: implications for the patient-physician relationship. JAMA 2000, 284(17):2240-2245.
29. Kravitz Richard L., Epstein Ronald M., Feldman Mitchell D., Franz Carol E., Azari Rahman, Wilkes Michael S., Hinton Ladson, Franks Peter Influence of patients' requests for directly advertised antidepressants: a randomized controlled trial. JAMA 2005, 293(16):1995-2002.
30. Li Yongbin, Jing Xu., Wang Fang, Wang Bin, Liu Liqun, Hou Wanli, Fan Hong, Tong Yeqing, Zhang Juan, Zuxun Lu. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Aff. 2012, 31(5):1075-1082.
31. Liu Xingzhu, Liu Yuanli, Chen Ningshan The Chinese experience of hospital price regulation. Health Policy Plan. 2000, 15:157-163.
32. Lu Fangwen Insurance coverage and agency problems in doctor prescriptions: evidence from a field experiment in China. J. Dev. Econ. 2014, 106(1):156-167.
33. Maguire Phyllis How direct-to-consumer advertising is putting the squeeze on physicians. Am. Coll. Physicians Ann. Intern. Med. 1999, 19:1-24.
34. Ministry of Health PRC, State Administration of Traditional Chinese Medicine of the People's Republic of China, Health Department of General Logistics Guiding principles for clinical application of antibacterial, No. [2004]285 2004, (in Chinese).
35. Ministry of Health PRC National Essential Medicine List (2012), No. 93 2013, (in Chinese).
36. Mintzes Barbara, Barer Morris L., Kravitz Richard L., Bassett Ken, Lexchin Joel, Kazanjian Arminée, Evans Robert G., Pan Richard, Marion Stephen A. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Can. Med. Assoc. J. 2003, 169:405-412.
37. Orlowski James P., Wateska Leon The effects of pharmaceutical firm enticements on physician prescribing patterns: there's no such thing as a free lunch. Chest 1992, 102:270-273.
38. Pager Devah Use of field experiments for studies of employment discrimination: contributions, critiques, and directions for the future. Ann. Am. Acad. Pol. Soc. Sci. 2007, 609:104-133.
39. State Council, PRC Major Working Arrangement on Deepening the Reform of the Medical and Health Care System in 2013, No. [2013]80 2013, (in Chinese).
40. State Council, PRC Guidance on the Consolidation and Perfection of the Essential Medicine System and the New Mechanism for Primary-level Operation, No. [2013]14 2013, (in Chinese).
41. Steinman Michael A., Shlipak Michael G., McPhee Stephen J. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotion. Am. J. Med. 2001, 110:551-557.
42. Sun Qiang A Survey of Medicine Prices, Availability, Affordability and Price Components in Shandong Province, China 2005, Health Action International (HAI), Geneva, (http://www.haiweb.org/medicineprices/surveys/200411CN/survey_report.pdf).
43. Sun Qiang, Santoro Michael A., Meng Qingyue, Liu Caitlin, Eggleston Karen Pharmaceutical policy in China. Health Aff. 2008, 27(4):1042-1050.
44. Sun Xiaoyun, Jackson Sukhan, Carmichael Gordon A., Sleigh Adrian C. Prescribing behavior of village doctors under China's New Cooperative Medical Scheme. Soc. Sci. Med. 2009, 68:1775-1779.
45. Tamblyn Robyn, Dale Dauphinee W., Grad Rolan, McLeod Peter, Snell Linda Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice. Ann. Intern. Med. 1997, 15:429-438.
46. Wagstaff Adam, Yip Winnie C., Lindelow Magnus, Hsiao William C. China's health system and its reform: a review of recent studies. Health Econ. 2009, 18(S2):S7-S23.
47. Wang Y.Richard Price competition in the Chinese pharmaceutical market. Int. J. Health Care Finance Econ. 2006, 6(2):119-129.
48. Wang Heng, Li Niannian, Zhu Haidi, Shuman Xu., Hua Lu., Feng Zhanchun Prescription pattern and its influencing factors in Chinese county hospitals: a retrospective cross-sectional study. PLoS One 2013, 8(5):e63225.
49. Wang Xin, Yu Changze, Wang Jiaji Performance appraisal method under general practitioner team model. Chin. Gen. Pract. 2013, 16(9):2941-2943. (in Chinese).
50. Wazana Ashley Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA 2000, 283:373-380.
51. Weissman Joel S., Dubois Robert W., Bodenheimer Thomas, Batchlor Elaine, Laouri Marianne, Avorn Jerry, Calfee John E., Gahart Martin T. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff. 2003, 22:82-95.
52. Yang Hao, Hassan H., Dib Minmin Zhu, Qi Gang, Zhang Xinping Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Health Policy Plan. 2010, 25(3):219-229.
53. Yao Kaihu, Yang Yonghong Streptococcus pneumoniae diseases in Chinese children: past, present and future. Vaccine 2008, 26(35):4425-4433.
54. Yin Xiaoxv, Song Fujian, Gong Yanhong, Xiaochen Tu., Wang Yunxia, Cao Shiyi, Liu Junan, Zuxun Lu. A systematic review of antibiotic utilization in China. J. Antimicrob. Chemother. 2013, 68(11):2445-2452.
55. Yip Winnie C. Physician response to medicare fee reductions: changes in the volume of coronary artery bypass graft (CABG) surgeries in the medicare and private sectors. J. Health Econ. 1998, 17:675-699.
56. Yip Winnie C., Hsiao William C. The Chinese health system at a crossroads. Health Aff. 2008, 27:460-468.
57. Yip Winnie C., Hsiao William C., Meng Qingyue, Chen Wen, Sun Xiaoming Realignment of incentives for health-care providers in China. Lancet 2010, 375(9720):1120-1130.
58. Yip Winnie C., William C., Hsiao Wen Chen, Shanlian Hu., Ma Jin, Maynard Alan Early appraisal of China's huge and complex health-care reforms. Lancet 2012, 379:833-842.
59. Yu Xuan, Li Cheng, Shi Yuhua, Yu Min Pharmaceutical supply chain in China: current issues and implications for health system reform. Health Policy 2010, 97:8-15.
60. Yu Miao, Zhao Genming, Lundborg Cecilia Stålsby, Zhu Yipin, Zhao Qi, Biao Xu. Knowledge, attitudes, and practices of parents in rural China on the use of antibiotics in children: a cross-sectional study. BMC Infect. Dis. 2014, 14:112.
61. Zhang Ruifang, Eggleston Karen, Rotimi Vincent, Zeckhauser Richard Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Glob. Health 2006, 2:1-14.
62. Zhu Hengpeng The endogeneity of control and its consequence: example of medicine price regulation. J. World Econ. 2011, 7:64-90. (in Chinese).